11 |
COMPETITIVE LANDSCAPE ..................................................................................................... 120 |
||
11.1 |
OVERVIEW ....................................................................................................................................................................... 120 |
||
11.2 |
LEADING PLAYERS IN THE GENOME EDITING MARKET ................................................................................................. 121 |
||
11.3 |
COMPETITIVE SITUATION AND TRENDS ........................................................................................................................ 122 |
||
11.3.1 |
AGREEMENTS , COLLABORATIONS , AND PARTNERSHIPS .......................................................................... 123 |
||
11.3.2 |
NEW PRODUCT AND SERVICE LAUNCHES ................................................................................................. 124 |
||
11.3.3 |
ACQUISITIONS ............................................................................................................................................. 125 |
||
11.3.4 |
EXPANSIONS ................................................................................................................................................ 126 |
||
11.3.5 |
OTHER DEVELOPMENTS .............................................................................................................................. 127 |
||
12 |
COMPANY PROFILES ............................................................................................................... 128 |
12.1 |
INTRODUCTION ............................................................................................................................................................... 128 |
12.2 |
THERMO FISHER SCIENTIFIC , INC ................................................................................................................................. 129 |
12.3 |
HORIZON DISCOVERY GROUP PLC ................................................................................................................................ 132 |
12.4 |
SIGMA-ALDRICH CORPORATION .................................................................................................................................... 135 |
12.5 |
GENSCRIPT USA INC ...................................................................................................................................................... 138 |
12.6 |
SANGAMO BIOSCIENCES , INC ....................................................................................................................................... 139 |
12.7 |
INTEGRATED DNA TECHNOLOGIES , INC ........................................................................................................................ 141 |
12.8 |
LONZA GROUP LTD . ( SWITZERLAND )............................................................................................................................. 142 |
12.9 |
NEW ENGLAND BIOLABS , INC . ( U . S .)............................................................................................................................. 143 |
12.10 ORIGENE TECHNOLOGIES , INC . ( U . S .)........................................................................................................................... 144 | |
12.11 TRANSPOSAGEN BIOPHARMACEUTICALS , INC . ( U . S .)................................................................................................. 146 |
13 |
APPENDIX ................................................................................................................................ 148 |
|
13.1 |
INSIGHTS OF INDUSTRY EXPERTS ................................................................................................................................. 148 |
|
13.2 |
DISCUSSION GUIDE ........................................................................................................................................................ 149 |
|
13.3 |
INTRODUCING RT : REAL-TIME MARKET INTELLIGENCE ................................................................................................ 151 |
|
13.4 |
AVAILABLE CUSTOMIZATIONS ....................................................................................................................................... 152 |
|
13.5 |
RELATED REPORTS ......................................................................................................................................................... 153 |